Related Experiment Video
Updated: Jul 20, 2026

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension
Published on: May 17, 2024
Hypertension: which aspects of hypertension should we impact on and how?
Alberto Zanchetti1, Bernard Waeber
1Centro di Fisiologia Clinica e Ipertensione, Università di Milano, Istituto Auxologico Italiano, Ospedale Maggiore, Milan, Italy. alberto.zanchetti@unimi.it
Insights
Lowering blood pressure in hypertensive patients prevents cardiovascular complications. A fixed combination of an angiotensin-converting enzyme inhibitor and a diuretic effectively lowers systolic pressure.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Hypertension management is crucial for preventing cardiovascular complications.
- International guidelines recommend blood pressure below 140/90 mmHg, with lower targets for patients with diabetes or renal impairment.
- Systolic blood pressure is a key indicator of cardiovascular risk and arterial stiffness.
Purpose of the Study:
- To evaluate the antihypertensive efficacy of a fixed-dose combination therapy compared to monotherapy.
- To assess the impact on systolic and diastolic blood pressure control.
Main Methods:
- The STRATHE Study compared a fixed low-dose combination of perindopril (angiotensin-converting enzyme inhibitor) and indapamide (diuretic) against other therapeutic strategies.
- Participants included hypertensive patients, with a focus on achieving target blood pressure values.
Main Results:
- The fixed-dose combination demonstrated greater antihypertensive efficacy, particularly in reducing systolic pressure, compared to single-agent therapies.
- This combination facilitated reaching target blood pressure levels more effectively.
Conclusions:
- Fixed-dose antihypertensive combinations, such as perindopril/indapamide, are a validated and effective option for initiating treatment in hypertensive patients.
- This approach offers improved systolic pressure control and overall cardiovascular risk reduction.
Abstract:
Cardiovascular complications may, to a large extent, be prevented by lowering blood pressure in hypertensive patients. International recommendations currently stress the importance of reaching values of below 140/90 mmHg in each patient or even lower in the case of concomitant diabetes or renal impairment. It is currently considered crucial to control the systolic pressure as well as the diastolic pressure, in particular because the relationship between cardiovascular risk and blood pressure is closer for the systolic than the diastolic value. An increase in systolic pressure is in itself a sign of the stiffening of the arterial tree. In most patients, the target pressure may only be reached by combining several different antihypertensive agents. In the STRATHE Study, a greater antihypertensive efficacy, in particular on systolic pressure, was obtained by instituting treatment with a fixed low-dose combination of an angiotensin-converting enzyme inhibitor (perindopril) and a diuretic (indapamide), in comparison with other therapeutic strategies based on single-agent therapy. Fixed-dose antihypertensive combinations have now become a validated option for initiating antihypertensive treatment.
Related Concept Videos
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension and Regulation of Blood Pressure
Hypertension V: Nursing Management
Factors affecting Blood pressure
Physiological Factors:
Hypertension I: Introduction
Hypertension II: Pathophysiology